myTomorrows is a healthcare technology company founded in 2012 that connects patients and their physicians with clinical trials and expanded access programmes worldwide once standard treatment options have been exhausted. Its work sits at the intersection of healthcare, biopharma and clinical trials, with a technical focus on AI-powered patient-trial matching, clinical trial data aggregation and platform technology supporting expanded access.
The company's main product, the myTomorrows Platform, links patients and physicians to trials and expanded access programmes across a global scope. AI-Powered Trial Matching applies artificial intelligence to identify suitable clinical trials for individual patients, while a multilingual Patient Navigator team provides personalised support throughout the treatment-access journey.
myTomorrows describes its purpose as making tomorrow's treatments available today for patients who need them most. The mission is rooted in the founder's experience: Ronald Brus lost his father to lung cancer in 2012, the year the company was established. The team comprises healthcare and technology professionals, and the company collaborates with biopharma companies, healthcare professionals and patient advocacy groups.
